Vir Biotechnology is a commercial-stage immunology company focused on developing antibody-based medicines to address critical health challenges, including COVID-19 and Ebola. The company leverages its next-generation antibody platform and PRO-XTEN™ masking technology to rapidly advance therapeutic candidates from concept to clinic. With a strong emphasis on infectious diseases, particularly hepatitis delta and hepatitis B, Vir is also exploring strategic programs in oncology. Their experienced leadership team is dedicated to delivering transformative options for patients, positioning Vir as a key player in the immunology space.

Administration

Marketing & Communications

Product

Sales & Business Development

Operations

San Francisco, CA, USA

Vir Biotechnology

Therapeutics

S32 is a venture capital fund founded by Bill Maris.

Section 32, LLC

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Section 32 Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Section 32 network as they come up.

You can always update this information later.

Welcome to the Section 32 talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Your professional information is now visible to our team and companies in our network.
We will be in touch when we find a great opportunity for you at one of our companies.

Thanks for signing up

As our companies grow, they look to us to help them find the best talent.
Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.